Key Points • Long-term romiplostim treatment is effective in children with primary ITP; serial bone marrow biopsy results showed no new safety concerns.• Romiplostim injections resulted in 8 AEs of… Click to show full abstract
Key Points • Long-term romiplostim treatment is effective in children with primary ITP; serial bone marrow biopsy results showed no new safety concerns.• Romiplostim injections resulted in 8 AEs of neutralizing antibodies (romiplostim, n = 7 [transient n = 4]; TPO, n = 1 [transient n = 1]).
               
Click one of the above tabs to view related content.